Highlights:
-Early follow-up shows promising results with bioabsorbable stent in the superficial femoral artery
-Is the Cotavance withdrawal in the USA a setback for drug-eluting balloons?
-ACST-2 first results indicate carotid revascularisation is becoming safer
-Profile: Piergiorgio Cao
[pdfviewer width=”100%” height=”940px” beta=”true”]https://vascularnews.com/wp-content/uploads/sites/7/2016/02/56-Vascular-News-USA_low-res.pdf[/pdfviewer]
